These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response. Pagnan G; Di Paolo D; Carosio R; Pastorino F; Marimpietri D; Brignole C; Pezzolo A; Loi M; Galietta LJ; Piccardi F; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M Clin Cancer Res; 2009 Feb; 15(4):1199-209. PubMed ID: 19228726 [TBL] [Abstract][Full Text] [Related]
4. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864 [TBL] [Abstract][Full Text] [Related]
5. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676 [TBL] [Abstract][Full Text] [Related]
6. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709). ; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma. Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Montaldo PG; Gambini C; Allen TM; Bogenmann E; Ponzoni M Int J Cancer; 2003 May; 104(5):559-67. PubMed ID: 12594810 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Formelli F; Cavadini E; Luksch R; Garaventa A; Villani MG; Appierto V; Persiani S Cancer Chemother Pharmacol; 2008 Sep; 62(4):655-65. PubMed ID: 18066548 [TBL] [Abstract][Full Text] [Related]
9. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models. Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497 [TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma. Di Paolo D; Pastorino F; Zuccari G; Caffa I; Loi M; Marimpietri D; Brignole C; Perri P; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M; Pagnan G J Control Release; 2013 Sep; 170(3):445-51. PubMed ID: 23792118 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat. Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M Br J Cancer; 2001 Dec; 85(12):2004-9. PubMed ID: 11747346 [TBL] [Abstract][Full Text] [Related]
17. Fenretinide and its relation to cancer. Ulukaya E; Wood EJ Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131 [TBL] [Abstract][Full Text] [Related]
18. Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells. Lovat PE; Oliverio S; Corazzari M; Rodolfo C; Ranalli M; Goranov B; Melino G; Redfern CP; Piacentini M Cancer Res; 2003 Nov; 63(21):7310-3. PubMed ID: 14612528 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Kaposi's sarcoma in vivo by fenretinide. Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128 [TBL] [Abstract][Full Text] [Related]
20. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide. Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]